NCT05620251View on ClinicalTrials.gov

Response to BNT162b2 Vaccine in Adolescents With Type 1 Diabetes

CompletedOBSERVATIONAL
Enrollment

121

Participants

Timeline

Start Date

September 3, 2021

Primary Completion Date

February 28, 2022

Study Completion Date

June 12, 2022

Conditions
type1diabetes
Interventions
DIAGNOSTIC_TEST

Blood test

Assessment of humoral immune response

Trial Locations (1)

34722

Istanbul Medeniyet University, Professor Doctor Suleyman Yalcin city Hospital, Istanbul

All Listed Sponsors
lead

Istanbul Medeniyet University

OTHER